Table 1.
Clinical Parameters | No.# | Nuclear Staining | P Value | Clinical Parameters | No.# | Nuclear Staining | P Value | ||
---|---|---|---|---|---|---|---|---|---|
Low positive | Strong positive | Low positive | Strong positive | ||||||
Gender | Stage | ||||||||
Male | 30 | 20 | 10 | 0.165 | I~II | 24 | 18 | 6 | 0.582 |
Female | 44 | 35 | 9 | III~IV | 50 | 37 | 13 | ||
Age | IPI | ||||||||
< 60 | 55 | 43 | 12 | 0.161 | 0~2 | 48 | 39 | 9 | 0.099 |
≥ 60 | 19 | 12 | 7 | 3~4 | 22 | 14 | 8 | ||
B symptoms | Bulky mass | ||||||||
positive | 29 | 23 | 6 | 0.306 | ≥ 10 cm | 9 | 6 | 3 | 0.440 |
negative | 45 | 32 | 13 | < 10 cm | 55 | 47 | 16 | ||
LDH | Molecular subtypes | ||||||||
positive | 28 | 19 | 9 | 0.235 | GCB | 24 | 21 | 3 | 0.061 |
negative | 46 | 36 | 10 | non-GCB | 50 | 34 | 16 | ||
β2-MG | Treatment regimens | ||||||||
positive | 46 | 34 | 12 | 0.513 | CHOP | 31 | 22 | 9 | |
negative | 17 | 12 | 5 | R-CHOP | 27 | 19 | 8 | ||
ESR | |||||||||
positive | 38 | 28 | 10 | 0.406 | |||||
negative | 29 | 23 | 6 |